On Monday, Sanofi SA (ADR) (NYSE:SNY)’s shares declined -0.39% to $53.33.
Sanofi SA (ADR) (SNY) and Regeneron Pharmaceuticals, Inc. declared that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the U.S. Food and Drug Administration (FDA) recommended the approval of the investigational therapy Praluent® (alirocumab) Injection. The Committee voted 13 to 3 (with no abstentions) that Sanofi and Regeneron had sufficiently established that the low-density lipoprotein cholesterol (LDL-C, or bad cholesterol) lowering benefit of Praluent exceeds its risks to support approval in one or more patient populations.
The Committee’s recommendation was based on Praluent’s benefit-risk profile, following review of efficacy and safety data from more than 5,000 patients across 10 pivotal Phase 3 double-blind trials ranging from six months to two years. Clinical data from the ODYSSEY Phase 3 program show comprising, positive results in reducing LDL-C. Common adverse events that were more frequently stated in patients treated with Praluent than the control groups comprised of injection site reaction and pruritus (itching).
Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, counting Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; and Afrezza, an inhaled insulin to improve glycemic control, in addition to Toujeo, an insulin glargine.
Fifth Street Finance Corp. (NASDAQ:FSC)’s shares dropped -0.48% to $6.22.
Fifth Street Finance Corp. (FSC) declared that its portfolio company, HFG Holdings, LLC (“Healthcare Finance Group” or “HFG”), a specialty lender providing asset-backed lending and term loan products to various segments of the healthcare industry, has been sold to MidCap Financial. FSC attained HFG in June of 2013 and, together with administration, expanded the company’s suite of products and capabilities, positioning it for future growth.
Fifth Street Finance Corp. is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and administration buyouts in small and mid-sized companies. It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors.
At the end of Monday’s trade, GasLog Ltd (NYSE:GLOG)‘s shares dipped -2.02% to $15.05.
GasLog Ltd. (GLOG), an international owner, operator and manager of LNG Carriers, declared that it will release its financial results for the second quarter of 2015 before the market opens on Thursday, August 6, 2015.
GasLog Ltd., together with its auxiliaries, owns, operates, and manages vessels in the liquefied natural gas (LNG) market worldwide. It provides maritime services for the transportation of LNG; and LNG vessel administration services. As of February 27, 2015, the company operated 20 LNG carriers. It also had 6 LNG carriers operating under its technical administration for third parties. The company was incorporated in 2003 and is based in Monaco.
Leggett & Platt, Inc. (NYSE:LEG), ended its Monday’s trading session with -1.77% loss, and closed at $48.78.
Leggett & Platt, Incorporated (LEG), a diversified manufacturer of engineered products serving several major markets, will hold its quarterly conference call to talk about second quarter results on Friday, July 31, 2015, at 9:00 a.m. Eastern Time (8:00 a.m. Central Time).
Leggett & Platt, Incorporated designs and produces a range of engineered components and products worldwide. The company’s Residential Furnishings segment offers innersprings and wire forms; steel mechanisms and hardware, springs and seat suspensions, steel tubular seat frames, bed frames and ornamental beds, and adjustable beds; and structural fabrics, carpet underlay materials, and geo components.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
